Sathi Maiti
Optometrist · Seattle, WANPI 1457758187
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,112 of the $7,111 with a category attached, or 86.0%. 19 manufacturers reported payments, led by Alcon at 30.2% of the total. Reporting peaked in 2024 at $2,124 and has fallen 51.6% since, to $1,027 in 2025. Among optometrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $64.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Tarsus Pharmaceuticals, Inc.$1K
- Bausch & Lomb Americas Inc.$1K
- Sun Pharmaceutical Industries Inc.$472
- Oyster Point Pharma, Inc.$397
- Amgen$304
- plus $2K from 13 others
Across 3 payments — averaging $655.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Oyster Point Pharma, Inc.$2K
- Tarsus Pharmaceuticals, Inc.$300
What the payments were for
- Consulting fees$1903%
- Travel & lodging$77211%
- Food & beverage$6,11286%
- Gifts$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 18 | $2,150 |
| Tarsus Pharmaceuticals, Inc. | 15 | $1,119 |
| Bausch & Lomb Americas Inc. | 19 | $1,051 |
| Sun Pharmaceutical Industries Inc. | 15 | $472 |
| Oyster Point Pharma, Inc. | 6 | $397 |
| Amgen | 4 | $304 |
| AbbVie | 7 | $240 |
| Coopervision Inc. | 4 | $227 |
| Mallinckrodt Hospital Products Inc. | 9 | $199 |
| Novartis | 3 | $192 |
| Dompe US, Inc. | 2 | $157 |
| Harrow Eye, LLC | 2 | $143 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 1 | $111 |
| Ocular Therapeutix, Inc. | 1 | $88 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $62 |
| Thea Pharma Inc. | 1 | $38 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,111 in reported general payments places this provider in the 95th percentile of 1,267 optometrist providers in Washington.
Other optometrist in Seattle
- Roya HabibiSeattle$109K
- Anita LamSeattle$30K
- Huy HoangSeattle$11K
- Jemimah CorpuzSeattle$8K
- Leslie LungSeattle$7K
- Gregory ChinSeattle$6K
- Leigh KimSeattle$6K
- Steve BirdSeattle$5K
- Kerri SvandaSeattle$5K
- David KadingKirkland$397K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.